Clinical Trial Update: Effects of Lactobacillus Reuteri in Premature Infants [NA]

View source ↗

Summary

A clinical trial evaluating the effects of the probiotic Lactobacillus reuteri in premature infants was terminated; no results are provided in the update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Premature Infant Disease

Drugs mentioned

• Lactobacillus reuteri (Lactobacillus reuteri)

Snippet

Sponsor: University of Miami | Conditions: Premature Infant Disease | NA | Status: TERMINATED